Repligen Corp.
(NASDAQ : RGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc. -0.06%81.120.7%$1566.02m
JNJJohnson & Johnson 0.19%163.710.7%$997.82m
PFEPfizer Inc. 0.77%43.190.9%$901.42m
ABBVAbbVie, Inc. 0.42%109.221.9%$661.78m
BMYBristol-Myers Squibb Co. -0.38%57.591.0%$625.23m
LLYEli Lilly & Co. 1.07%243.751.1%$585.84m
AZNAstraZeneca Plc 0.93%61.791.0%$310.35m
NVSNovartis AG 0.31%84.930.2%$174.90m
GSKGlaxoSmithKline Plc 0.58%39.780.2%$162.05m
AVIRAtea Pharmaceuticals, Inc. -0.16%12.730.3%$125.28m
RGENRepligen Corp. 1.55%274.956.8%$113.28m
NVONovo Nordisk A/S 1.51%105.990.1%$89.92m
VTRSViatris, Inc. -0.50%13.940.0%$87.91m
SNYSanofi 1.44%49.920.2%$70.53m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.27%139.980.0%$52.50m

Company Profile

Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. It serves through the following product lines: Chromatography, Filtration and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.